These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31451517)

  • 21. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
    Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPARα activation directly upregulates thrombomodulin in the diabetic retina.
    Shiono A; Sasaki H; Sekine R; Abe Y; Matsumura Y; Inagaki T; Tanaka T; Kodama T; Aburatani H; Sakai J; Takagi H
    Sci Rep; 2020 Jul; 10(1):10837. PubMed ID: 32616724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPAR
    Mandala A; Chen WJ; Armstrong A; Malhotra MR; Chavalmane S; McCommis KS; Chen A; Carpenter D; Biswas P; Gnana-Prakasam JP
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G262-G269. PubMed ID: 34287090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
    Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.
    Cho YR; Lim JH; Kim MY; Kim TW; Hong BY; Kim YS; Chang YS; Kim HW; Park CW
    PLoS One; 2014; 9(1):e83204. PubMed ID: 24392081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
    Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.
    Kuno T; Hata K; Takamatsu M; Hara A; Hirose Y; Takahashi S; Imaida K; Tanaka T
    Int J Mol Sci; 2014 May; 15(5):9160-72. PubMed ID: 24857924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
    Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
    Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective and antioxidant effects of PPARα in the ischemic retina.
    Moran E; Ding L; Wang Z; Cheng R; Chen Q; Moore R; Takahashi Y; Ma JX
    Invest Ophthalmol Vis Sci; 2014 May; 55(7):4568-76. PubMed ID: 24825105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fenofibrate improves vascular endothelial function and contractility in diabetic mice.
    Xu N; Wang Q; Jiang S; Wang Q; Hu W; Zhou S; Zhao L; Xie L; Chen J; Wellstein A; Lai EY
    Redox Biol; 2019 Jan; 20():87-97. PubMed ID: 30296701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
    Grabacka M; Plonka PM; Urbanska K; Reiss K
    Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
    Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
    Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
    Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
    Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression.
    Enright JM; Zhang S; Thebeau C; Siebert E; Jin A; Gadiraju V; Zhang X; Chen S; Semenkovich CF; Rajagopal R
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceramide 1-Phosphate Protects Endothelial Colony-Forming Cells From Apoptosis and Increases Vasculogenesis In Vitro and In Vivo.
    Mena HA; Zubiry PR; Dizier B; Mignon V; Parborell F; Schattner M; Boisson-Vidal C; Negrotto S
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):e219-e232. PubMed ID: 31434496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.